Here are five key points:
1. Francisco Ponce, MD, of Barrow Neurological Institute in Phoenix, implanted the first TYRX Neuro envelopes.
2. A surgical mesh envelope, the TYRX Neuro locks an implantable neurostimulator or cardiac implantable electronic device in place.
3. Once implanted, it releases minocycline and rifampin over seven days to prevent surgical site infections.
4. Nine weeks after the implantation operation, the body completely absorbs the TRYX Neuro.
5. The FDA has cleared TRYX Neuro’s use with CIEDs and INS systems.
“The TYRX Neuro Absorbable Antibacterial Envelope is a much needed and long awaited solution to the risk of infection related to implanted neurostimulator,” said Dr. Ponce. “It is going to be the standard of care in my practice.”
More articles on devices:
Dr. Faheem Sandhu performs 1st FacetLINK HEMI implantation in the US: 5 key points
Global minimally invasive neurosurgery devices market on the rise: 5 things to know
Smith & Nephew’s VISIONAIRE Cutting Guides successfully used in 1st surgery in Latin America: 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
